Clinical Trial Update: Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of Aczone 7.5% Gel for truncal acne vulgaris has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• Aczone 7.5% Gel (dapsone gel 7.5%)

Snippet

Sponsor: Derm Research, PLLC | Conditions: Acne | Phase 4 | Status: COMPLETED | Results posted: 2019-03-01